Nachrichten zur Quest Diagnostics Inc. Aktie

Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year

Cautious investors have long known that healthcare spending rises steadily regardless of the direction of the overall economy. Its considered…

Quest Diagnostics declares $0.75 dividend

…

Heres Why You Should Retain DGX Stock in Your Portfolio Now

Investors feel optimistic about Quest Diagnostics strength in Advanced Diagnostics. Robust base business volumes are also encouraging.…

Quest Diagnostics: Neue KI-Tools zur Krebs-Früherkennung schieben Ergebnis deutlich an!

Geschäftstreiber: Quest Diagnostics (DGX) gehört zu den weltweit führenden Anbietern im Bereich klinischer Test- und Diagnostik-Verfahren rund um verschiedene Segmente.…

Quest Diagnostics stock hits 52-week high of $159.46 By Investing.com

Quest Diagnostics stock hits 52-week high of $159.46…

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

…

DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up

Quest Diagnostics third-quarter 2024 performance reflects impressive DIS business growth and the benefits of new acquisitions.…

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

…

DGX Gears Up for Q3 Earnings: What Lies Ahead for the Stock?

Quest Diagnostics is expected to deliver robust base business growth in the third quarter of 2024.…

Quest Diagnostics Stock Gains From New Offerings, Customer Wins

A key driver in Brain Health growth is Quest Diagnostics Alzheimers disease portfolio, featuring the AD-Detect blood testing services and…

DGX Stock to Benefit From New Partnership With Sentara Health Plans

Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.…

DGX Stock Likely to Gain From Allina Healths Select Lab Assets Buyout

With the completion of the acquisition, Allina Healths clinic physicians will now have access to Quest Diagnostics laboratory services.…

Investing in Quest Diagnostics (NYSE:DGX) five years ago would have delivered you a 60% gain

When you buy and hold a stock for the long term, you definitely want it to provide a positive return.…

BCAL Commences US Operations

BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) is pleased to announce that it has established a North Carolina,…

Quest Diagnostics Expands in North America With New Acquisition

DGX acquires 100% of LifeLabs from OMERS, at approximately $1 billion. It will help LifeLabs to improve healthcare for Canadians.…

Quest Diagnostics (DGX) New Deal Aids Diagnostic Access in Ohio

Quest Diagnostics (DGX) signs an agreement to acquire select assets of University Hospitals outreach laboratory services business.…

Quest Diagnostics (DGX) Debuts Micronutrient Deficiency Panels

Quest Diagnostics (DGX) introduces 13 blood tests to identify micronutrient deficiencies.…

Quest Diagnostics (DGX) New Study Exposes Alarming Data on STI

Quest Diagnostics (DGX) joint study with the University of Alabama finds pregnant women undertested for STIs, raising serious concerns on…

Quest Diagnostics stock hits 52-week high at $151.94 By Investing.com

Quest Diagnostics stock hits 52-week high at $151.94…

Should Quest Diagnostics (DGX) be in Your Portfolio Now?

Quest Diagnostics (DGX) robust base business performance instills optimism for long-term growth.…

Quest Diagnostics (DGX) Gains From Innovation, Customer Wins

A key driver in Brain Health growth is Quest Diagnostics (DGX) Alzheimers disease portfolio, featuring the AD-Detect blood testing services…

Quest Diagnostics (DGX) Haystack Oncology Forges New MRD Deal

Quest Diagnostics (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.…

Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.73% and 0.50%, respectively, for the quarter ended June 2024. Do…

Quest Diagnostics: On A Quest For Growth

…

What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?

Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However,…

Quest Diagnostics to acquire certain assets from OhioHealth

…

Global Precision Diagnostics Market Size To Worth USD 254.48 Billion By 2033 | CAGR Of 13%

The Global Precision Diagnostics Market Size was Valued at USD 74.98 Billion in 2023 and the Worldwide Precision Diagnostics Market…

Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout

By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for…

Global PCOS Diagnostic Market Size To Exceed USD 6.1 Billion By 2033 | CAGR Of 5.18%

The Global PCOS Diagnostic Market Size was Valued at USD 3.68 Billion in 2023 and the Worldwide PCOS Diagnostic Market…

Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?

Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues…

PTA-News: Small- & MicroCap Investment: KI als Wachstumsmotor: CrowdStrike, Adcore, Quest Diagnostics

DJ PTA-News: Small- & MicroCap Investment: KI als Wachstumsmotor: CrowdStrike, Adcore, Quest Diagnostics Unternehmensmitteilung für den Kapitalmarkt Frankfurt (pta/23.06.2024/10:00) -…

Quest Diagnostics (DGX) Gains From New M&As Amid Competition

In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share…

Quest Diagnostics (DGX) New Buyout Ramps Up Cancer Diagnosis

Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer…

Analyst Report: Quest Diagnostics, Inc.

…

Quest Diagnostics said to be nearing deal for Canadas Lifelabs

…

Kaum Impulse für die Quest Diagnostics-Aktie (127,3380 €)

Wenig Kursbewegung aktuell bei der Aktie von Quest Diagnostics . Der jüngste Kurs betrug 136,84 US-Dollar. Die Wertschätzung der Börsenteilnehmer…

Quest Diagnostics: Lets Keep Waiting

…

Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal

Quest Diagnostics (DGX) pathology laboratories nationwide are set to get a boost with PathAIs AISight digital pathology image management system.…

Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics

Quest Diagnostics (DGX) latest transaction combines its oncology expertise and scale with PathAIs AI and digital pathology innovations.…

Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.…

Minimale Kursveränderung bei Quest Diagnostics-Aktie (120,7245 €)

CODE Das Wertpapier notiert aktuell bei 128,30 US-Dollar. Kaum auffällig ist derzeit an der Börse der Kurs von Quest Diagnostics.…

Quest Diagnostics (DGX) to Post Q1 Earnings: Whats in Store?

Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics (DGX) base business performance in the first quarter…

Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs

Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal…

Analyst Report: Quest Diagnostics, Inc.

…

Quest Diagnostics (DGX) Hurt by Lower Testing Sales, Competition

Quest Diagnostics (DGX) faces intense competition, primarily from LabCorp as well as other commercial laboratories and hospitals.…

Quest Diagnostics (DGX) Boosts Oncology Portfolio With New Test

Quest Diagnostics (DGX) debuts the MelaNodal Predict test in collaboration with SkylineDx.…

Quest Diagnostics (DGX) Debuts PFAS Blood Test Offering

Quest Diagnostics (DGX) introduces the first consumer-initiated blood test with physician consult on questhealth.com.…

Reasons to Retain Quest Diagnostics (DGX) Stock for Now

Strength of the base business bodes well for Quest Diagnostics (DGX).…

Earnings call: Quest Diagnostics sees robust growth and AI investment By Investing.com

Earnings call: Quest Diagnostics sees robust growth and AI investment…

Quest Diagnostics-Aktie heute am Aktienmarkt kaum gefragt: Kurs fällt (116,0444 €)

Im Minus liegt derzeit die Aktie von Quest Diagnostics . Das Papier kostete zuletzt 126,16 US-Dollar. Im US-amerikanischen Wertpapierhandel hat…